Policy Paper

Follow-on Biologics

in Program

As the biopharmaceutical industry expands to include a follow-on market, careful attention should be paid to ensure that new companies that handle select agents, and produce select agent derived products, are required to come under strict standards of management, use, and distribution of raw agents and finished product.

Share on twitter
Share on facebook
Share on linkedin
Share on email
Choose Your Subscription Topics
* indicates required
I'm interested in...
38 North: News and Analysis on North Korea
South Asian Voices